IL261343A - Transposon system and methods of use - Google Patents
Transposon system and methods of useInfo
- Publication number
- IL261343A IL261343A IL261343A IL26134318A IL261343A IL 261343 A IL261343 A IL 261343A IL 261343 A IL261343 A IL 261343A IL 26134318 A IL26134318 A IL 26134318A IL 261343 A IL261343 A IL 261343A
- Authority
- IL
- Israel
- Prior art keywords
- methods
- transposon system
- transposon
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/07—Nucleotidyltransferases (2.7.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/90—Vectors containing a transposable element
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662300387P | 2016-02-26 | 2016-02-26 | |
| PCT/US2017/019531 WO2017147538A1 (en) | 2016-02-26 | 2017-02-24 | Transposon system and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL261343A true IL261343A (en) | 2018-10-31 |
Family
ID=58314517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL261343A IL261343A (en) | 2016-02-26 | 2018-08-23 | Transposon system and methods of use |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP3420090A1 (en) |
| JP (1) | JP2019506177A (en) |
| KR (1) | KR20180131545A (en) |
| CN (1) | CN109312361A (en) |
| AU (1) | AU2017224111A1 (en) |
| BR (1) | BR112018067536A2 (en) |
| CA (1) | CA3015642A1 (en) |
| IL (1) | IL261343A (en) |
| MX (1) | MX2018010288A (en) |
| RU (1) | RU2018133691A (en) |
| SG (1) | SG11201807134RA (en) |
| WO (1) | WO2017147538A1 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190119636A1 (en) * | 2017-10-23 | 2019-04-25 | Poseida Therapeutics, Inc. | Modified stem cell memory t cells, methods of making and methods of using same |
| US11278570B2 (en) | 2016-12-16 | 2022-03-22 | B-Mogen Biotechnologies, Inc. | Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods |
| KR102523318B1 (en) | 2016-12-16 | 2023-04-18 | 비-모젠 바이오테크놀로지스, 인크. | Enhanced HAT family transposon-mediated gene delivery and associated compositions, systems, and methods |
| CN108728477B (en) * | 2017-04-24 | 2022-02-22 | 华东理工大学 | Efficient transposition mutation system and construction method |
| WO2019046815A1 (en) * | 2017-08-31 | 2019-03-07 | Poseida Therapeutics, Inc. | Transposon system and methods of use |
| CA3072777A1 (en) * | 2017-09-08 | 2019-03-14 | Poseida Therapeutics, Inc. | Compositions and methods for chimeric ligand receptor (clr)-mediated conditional gene expression |
| US10329543B2 (en) | 2017-10-23 | 2019-06-25 | Poseida Therapeutics, Inc. | Modified stem cell memory T cells, methods of making and methods of using same |
| WO2019246486A2 (en) | 2018-06-21 | 2019-12-26 | B-Mogen Biotechnologies, Inc. | ENHANCED hAT FAMILY TRANSPOSON-MEDIATED GENE TRANSFER AND ASSOCIATED COMPOSITIONS, SYSTEMS, AND METHODS |
| CN111926041B (en) * | 2020-10-16 | 2020-12-25 | 广州吉妮欧生物科技有限公司 | SARS-CoV-2 pseudovirus mouse internal packaging system and its preparation method |
| CN114246986B (en) * | 2021-12-29 | 2022-08-23 | 中国人民解放军陆军军医大学 | Cardiovascular implant based on in-situ immune response regulation and control and preparation method thereof |
| CN116590341A (en) * | 2023-07-13 | 2023-08-15 | 山东维真生物科技有限公司 | adenovirus-PiggyBac system and preparation method and application thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| US9228180B2 (en) | 2007-07-04 | 2016-01-05 | Max-Delbruck-Centrum Fur Molekulare Medizin | Polypeptide variants of sleeping beauty transposase |
| SG174155A1 (en) * | 2009-02-25 | 2011-10-28 | Univ Johns Hopkins | Piggybac transposon variants and methods of use |
| WO2010099296A1 (en) * | 2009-02-26 | 2010-09-02 | Transposagen Biopharmaceuticals, Inc. | Hyperactive piggybac transposases |
| US20130045491A1 (en) * | 2011-07-19 | 2013-02-21 | Derya Unutmaz | Methods for activating t cells |
| US20150322439A1 (en) * | 2012-11-19 | 2015-11-12 | Nature Technology Corporation | Replicative minicircle vectors with improved expression |
-
2017
- 2017-02-24 CN CN201780025816.1A patent/CN109312361A/en active Pending
- 2017-02-24 MX MX2018010288A patent/MX2018010288A/en unknown
- 2017-02-24 RU RU2018133691A patent/RU2018133691A/en not_active Application Discontinuation
- 2017-02-24 WO PCT/US2017/019531 patent/WO2017147538A1/en active Application Filing
- 2017-02-24 AU AU2017224111A patent/AU2017224111A1/en not_active Abandoned
- 2017-02-24 KR KR1020187027345A patent/KR20180131545A/en unknown
- 2017-02-24 EP EP17711046.7A patent/EP3420090A1/en not_active Withdrawn
- 2017-02-24 BR BR112018067536A patent/BR112018067536A2/en not_active IP Right Cessation
- 2017-02-24 SG SG11201807134RA patent/SG11201807134RA/en unknown
- 2017-02-24 JP JP2018544891A patent/JP2019506177A/en active Pending
- 2017-02-24 CA CA3015642A patent/CA3015642A1/en not_active Abandoned
-
2018
- 2018-08-23 IL IL261343A patent/IL261343A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019506177A (en) | 2019-03-07 |
| KR20180131545A (en) | 2018-12-10 |
| RU2018133691A (en) | 2020-03-26 |
| WO2017147538A1 (en) | 2017-08-31 |
| SG11201807134RA (en) | 2018-09-27 |
| CA3015642A1 (en) | 2017-08-31 |
| CN109312361A (en) | 2019-02-05 |
| EP3420090A1 (en) | 2019-01-02 |
| AU2017224111A1 (en) | 2018-09-13 |
| RU2018133691A3 (en) | 2020-07-29 |
| BR112018067536A2 (en) | 2019-02-05 |
| MX2018010288A (en) | 2019-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL286316A (en) | Novel micro-dystrophins and related methods of use | |
| IL250415B (en) | Anti-pdl- antibodies and methods of use thereof | |
| IL261343A (en) | Transposon system and methods of use | |
| HK1253049A1 (en) | Glycan-interacting compounds and methods of use | |
| ZA201608116B (en) | Wireline system and methods of using same | |
| IL251988A0 (en) | Glycan-interacting compounds and methods of use | |
| GB2544180B (en) | Cover means and method of use thereof | |
| IL282482A (en) | Protoxin-ii variants and methods of use | |
| GB201514760D0 (en) | Compounds and method of use | |
| GB201609786D0 (en) | Compounds and method of use | |
| IL282508A (en) | Protoxin-ii variants and methods of use | |
| PL3089971T3 (en) | Compounds and methods of use | |
| ZA201606450B (en) | Compounds and their methods of use | |
| GB2548269B (en) | Exercise system and method of use thereof | |
| GB201421197D0 (en) | Apparatus and method of use thereof | |
| SG10201702547QA (en) | Methods of vibro-treating and vibro-treating apparatus | |
| GB201616267D0 (en) | Multiplexing apparatus and method of use thereof | |
| GB201418712D0 (en) | System and method of watermarking | |
| GB201403697D0 (en) | Compounds and methods of use | |
| GB201619451D0 (en) | Barrier system and method of use thereof | |
| GB201807613D0 (en) | Underwater apparatus and method of use thereof | |
| GB201501257D0 (en) | Cover means and method of use thereof | |
| GB201420747D0 (en) | Exercise system and method of use thereof | |
| GB201416797D0 (en) | Contianer and method of use thereof | |
| GB201508694D0 (en) | Construction apparatus and method of use thereof |